Home NDC 0548-5701 Medroxyprogesterone Acetate
Product NDC 0548-5701
11-digit product format 005485701
Labeler code 0548
Product ID 0548-5701_fe3eb29d-0024-4834-a1af-81661804f532
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name Medroxyprogesterone acetate
Dosage form INJECTION, SUSPENSION, EXTENDED RELEASE
Route INTRAMUSCULAR
Labeler Amphastar Pharmaceuticals, Inc.
Application ANDA077334
Marketing category ANDA
Marketing start 2017-11-28
Substance MEDROXYPROGESTERONE ACETATE
Active strength 150 mg/mL
Pharmacologic classes Progesterone Congeners [CS], Progestin [EPC]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A077334-001 MEDROXYPROGESTERONE ACETATE MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A077334-001 AB
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 87673890dc5c…2021-03-12 10:30 UTC 2021-03 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 3f01610625f2…2019-09-15 20:21 UTC 2019-09 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 b00525d2431f…2019-07-19 19:46 UTC 2019-07 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A077334-001 MEDROXYPROGESTERONE ACETATE 150MG/ML INJECTABLE / INJECTION AB 2017-11-28 e64feba35796…
Observed Orange Book normalized TE history# Normalized TE history page 1 of 2 · 42 observed states.
Additional Listing Data#
Finished product Yes
Brand name base Medroxyprogesterone Acetate
Listing expiration 2027-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength MEDROXYPROGESTERONE ACETATE 150 mg/mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination C2QI4IOI2G Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 2 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 1000126 Internal RxNorm lookup 1000153 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 0548-5701 MEDROXYPROGESTERONE ACETATE INJECTION, SUSPENSION, EXTENDED RELEASE [AMPHASTAR PHARMACEUTICALS, INC.] 7 Current NDC, Legacy NDC 20211216_fda1aa8a-5739-482a-b4f6-9741ef4d9977.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Marketing end Sample Exclude flag Status 0548-5701-00 00548570100 1 SYRINGE in 1 CARTON (0548-5701-00) / 1 mL in 1 SYRINGE 1 syringe 2017-11-28 0000-00-00 No No Current